Follow
MinYuen Teo
Title
Cited by
Cited by
Year
Treatment of advanced prostate cancer
MY Teo, DE Rathkopf, P Kantoff
Annual review of medicine 70, 479-499, 2019
5352019
Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
MY Teo, K Seier, I Ostrovnaya, AM Regazzi, BE Kania, MM Moran, ...
Journal of Clinical Oncology 36 (17), 1685, 2018
4482018
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ...
Cell 185 (3), 563-575. e11, 2022
2662022
DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ...
Clinical cancer research 23 (14), 3610-3618, 2017
2392017
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
RM Bambury, MY Teo, DG Power, A Yusuf, S Murray, JE Battley, C Drake, ...
Journal of neuro-oncology 114, 149-154, 2013
2102013
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
RM Bambury, MY Teo, DG Power, A Yusuf, S Murray, JE Battley, C Drake, ...
Journal of neuro-oncology 114, 149-154, 2013
2102013
Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
EJ Pietzak, EC Zabor, A Bagrodia, J Armenia, W Hu, A Zehir, S Funt, ...
European urology 75 (2), 231-239, 2019
1232019
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
D Liu, P Abbosh, D Keliher, B Reardon, D Miao, K Mouw, A Weiner-Taylor, ...
Nature communications 8 (1), 2193, 2017
1142017
Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib
SJ Cushen, DG Power, MY Teo, P MacEneaney, MM Maher, R McDermott, ...
American journal of clinical oncology 40 (1), 47-52, 2017
1042017
Cancer susceptibility mutations in patients with urothelial malignancies
MI Carlo, V Ravichandran, P Srinavasan, C Bandlamudi, Y Kemel, ...
Journal of Clinical Oncology 38 (5), 406, 2020
772020
PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies
H Reis, R Serrette, J Posada, V Lu, Y Chen, A Gopalan, SW Fine, ...
The American journal of surgical pathology 43 (7), 920-927, 2019
692019
Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: a multicenter, single-arm, phase II trial
SA Funt, M Lattanzi, K Whiting, H Al-Ahmadie, C Quinlan, MY Teo, ...
Journal of Clinical Oncology 40 (12), 1312, 2022
532022
Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?
J Naidoo, MY Teo, S Deady, H Comber, P Calvert
Journal of Thoracic Oncology 8 (9), 1215-1221, 2013
502013
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
Y Ged, JL Chaim, RG DiNatale, A Knezevic, RR Kotecha, MI Carlo, ...
Journal for immunotherapy of cancer 8 (1), 2020
422020
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
P Grivas, Y Loriot, R Morales-Barrera, MY Teo, Y Zakharia, S Feyerabend, ...
BMC cancer 21 (1), 593, 2021
352021
NUT Midline Carcinoma in a Young Woman
MY Teo, P Crotty, M O'Sullivan, CA French, JM Walshe
Journal of Clinical Oncology 29 (12), e336-e339, 2011
282011
Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial …
MY Teo, JM Mota, KA Whiting, HA Li, SA Funt, CH Lee, DB Solit, ...
European urology 78 (6), 907-915, 2020
272020
Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapy
MY Teo, MSNM Sharial, F McDonnell, KC Conlon, PF Ridgway, ...
Tumori Journal 99 (4), 516-522, 2013
262013
Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
JA Coleman, W Yip, NC Wong, DD Sjoberg, BH Bochner, G Dalbagni, ...
Journal of Clinical Oncology 41 (8), 1618-1625, 2023
252023
Nivolumab for the treatment of urothelial cancers
MY Teo, JE Rosenberg
Expert Review of Anticancer Therapy 18 (3), 215-221, 2018
242018
The system can't perform the operation now. Try again later.
Articles 1–20